Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
Noam Barda, Noa Dagan, Cyrille J. Cohen, Miguel A. Hernán, Marc Lipsitch, Isaac S. Kohane, Ben Y. Reis, Ran D. Balicer
Topics & Concepts
MedicineObservational studyBooster dosePopulationCoronavirus disease 2019 (COVID-19)Health careVaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PediatricsFamily medicineEmergency medicineInternal medicineDiseaseVirologyInfectious disease (medical specialty)Environmental healthVirusEconomic growthTiterEconomicsSARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinationsVaccine Coverage and Hesitancy